chloramphenicol has been researched along with Acquired Immunodeficiency Syndrome in 1 studies
Amphenicol: Chloramphenicol and its derivatives.
Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glaser, JB | 1 |
| Morton-Kute, L | 1 |
| Berger, SR | 1 |
| Weber, J | 1 |
| Siegal, FP | 1 |
| Lopez, C | 1 |
| Robbins, W | 1 |
| Landesman, SH | 1 |
1 other study available for chloramphenicol and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Recurrent Salmonella typhimurium bacteremia associated with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Ampicillin; Chloramphenicol; Diarrhea; Drug Combinations; | 1985 |